Gene expression profiling identifies IL-13 receptor α2 chain as a therapeutic target in prostate tumor cells overexpressing adrenomedullin

International Journal of Cancer

Volumn 114, Issue 6, 2005, Pages 870-878

  Gonzalez Moreno, Oscar ^a,b   Calvo, Alfonso ^a,b   Joshi, Bharat H ^c   Abasolo, Ibane ^b   Leland, Pamela ^c   Wang, Zhou ^d   Montuenga, Luis ^b   Puri, Raj K ^c   Green, Jeffrey E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF NAVARRA   (Spain)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Adrenomedullin; cDNA microarrays; Gene expression profiling; IL 13R 2; Prostate cancer

Indexed keywords

ADRENOMEDULLIN; CYTOKINE; CYTOTOXIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; INTERLEUKIN 13 RECEPTOR ALPHA2; SOMATOMEDIN BINDING PROTEIN 6; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX3;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL CYCLE; CELL GROWTH; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; DRUG TARGETING; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IC 50; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE TUMOR; PROTEIN EXPRESSION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; UPREGULATION;

EID: 17044393596     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20789     Document Type: Article

References (43)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
2. Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 1993;194:720-5.
3. Jiménez N, Calvo A, Martinez A, Rosell D, Cuttitta F, Montuenga LM. Expression of adrenomedullin and proadrenomedullin N-terminal 20 peptide in human and rat prostate. J Histochem Cytochem 1999;47:1167-78.
4. Rocchi P, Boudouresque F, Zamora AJ, Muracciole X, Lechevallier E, Martin PM, Ouafik L. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines. Cancer Res 2001;61:1196-206.
5. Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 2000;21:138-67.
6. Cuttitta F, Pio R, Garayoa M, Zudaire E, Julian M, Elsasser TH, Montuenga LM, Martinez A. Adrenomedullin functions as an important tumor survival factor in human carcinogenesis. Microsc Res Tech 2002;57:110-9.
7. Caron KM, Smithies O. Multiple roles of adrenomedullin revealed by animal models. Microsc Res Tech 2002;57:55-9.
8. Miller MJ, Martinez A, Unsworth EJ, Thiele CJ, Moody TW, Elsasser T, Cuttitta F. Adrenomedullin expression in human tumor cell lines: its potential role as an autocrine growth factor. J Biol Chem 1996;271:23345-51.
9. Upton PD, Wharton J, Coppock H, Davie N, Yang X, Yacoub MH, Ghatei MA, Polak JM, Bloom SR, Smith DM, Morrell NW. Adrenomedullin expression and growth inhibitory effects in distinct pulmonary artery smooth muscle cell subpopulations. Am J Respir Cell Mol Biol 2001;24:170-8.
10. Kapas S, Brown DW, Farthing PM, Hafi-Pavli E. Adrenomedullin has mitogenic effects on human oral keratinocytes: involvement of cyclic AMP. FEBS Lett 1997;418:287-90.
11. Szokodi I, Kinnunen P, Tavi P, Weckstrom M, Toth M, Ruskoaho H. Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide. Circulation 1998;97:1062-70.
12. Ali N, Yousufzai SY, Abdel-Latif AA. Activation of particulate guanylate cyclase by adrenomedullin in cultured SV-40 transformed cat iris sphincter smooth muscle (SV-CISM-2) cells. Cell Signal 2000;12:491-8.
13. Mazzocchi G, Albertin G, Andreis PG, Neri G, Malendowicz LK, Champion HC, Bahceliogla M, Kadowitz PJ, Nussdorfer GG. Distribution, functional role, and signaling mechanism of adrenomedullin receptors in the rat adrenal gland. Peptides 1999;20:1479-87.
14. Andreis PG, Neri G, Prayer-Galetti T, Rossi GP, Gottardo G. Malendowicz LK, Nussdorfer GG. Effects of adrenomedullin on the human adrenal glands: an in vitro study. J Clin Endocrinol Metab 1997;82:1167-70.
15. Tomoda Y, Isumi Y, Katafuchi T, Minamino N. Regulation of adrenomedullin secretion from cultured cells. Peptides 2001;22:1783-94.
16. Eto T, Kato J, Kitamura K. Regulation of production and secretion of adrenomedullin in the cardiovascular system. Regul Pept 2003;112:61-9.
17. Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, Matsuo H. Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 1995;207:25-32.
18. Isumi Y, Minamino N, Kubo A, Nishimoto N, Yoshizaki K, Yoshioka M, Kangawa K, Matsuo H. Adrenomedullin stimulates interleukin-6 production in Swiss 3T3 cells. Biochem Biophys Res Commun 1998;244:325-31.
19. Elsasser TH, Sartin JL, Martinez A, Kahl S, Montuenga L, Pio R, Fayer R, Miller M, Cuttitta F. Underlying disease stress augments plasma and tissue adrenomedullin (AM) responses to endotoxin: colocalized increases in AM and inducible nitric oxide synthase within pancreatic islets. Endocrinology 1999;140:5402-11.
20. Garayoa M, Martinez A, Lee S, Pio R, An WG, Neckers L, Trepel J, Montuenga LM, Ryan H, Johnson R, Gassmann M, Cuttitta F. Hypoxia-inducible factor-1 (HIF-1) upregulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol Endocrinol 2000;14:848-62.
21. Abasolo I, Yang L, Xiao W, Haleem R, Pío R, Cuttitta F, Montuenga LM, Kozlowski JM, Calvo A, Wang Z. Overexpression of adrenomedullin gene markedly inhibits proliferation of PC3 prostate cancer cells in vitro and in vivo. Mol Cell Endocrinol 2003;199:179-87.
22. Joshi BH, Kawakami K, Leland P, Puri RK. Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin. Clin Cancer Res 2002;8:1948-56.
23. Desai KV, Kavanaugh CJ, Calvo A, Green JE. Chipping away at breast cancer: insights from microarray studies of human and mouse mammary cancer. Endocr Relat Cancer 2002;9:207-20.
24. Murata T, Obiri NI, Puri RK. Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: comparison between IL-4- and IL-13-induced signal transduction. Int J Cancer 1997;70:230-40.
25. Kawakami K, Kawakami M, Snoy PJ, Husain SR, Puri RK. In vivo overexpression of IL-13 receptor alpha2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice. J Exp Med 2001;194:1743-54.
26. Ouafik L, Sauze S, Boudouresque F, Chinot O, Delfino C, Fina F, Vuaroqueaux V, Dussert C, Palmari J, Dufour H, Grisoli F, Casellas P, et al. Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. Am J Pathol 2002;160:1279-92.
27. Puri RK, Leland P, Obiri NI, Husain SR, Kreitman RJ, Haas GP, Pastan I, Debinski W. Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR). Blood 1996;87:4333-9.
28. Husain SR, Obiri NI, Gill P, Zheng T, Pastan I, Debinski W, Puri RK. Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein. Clin Cancer Res 1997;3:151-6.
29. Derst C, Engel H, Grzeschik K, Daut J. Genomic structure and chromosome mapping of human and mouse RAMP genes. Cytogenet Cell Genet 2000;90:115-8.
30. Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993;362:248-50.
31. Maini A, Hillman G, Haas GP, Wang CY, Montecillo E, Hamzavi F, Pontes JE, Leland P, Pastan I, Debinski W, Puri RK. Interleukin-13 receptors on human prostate carcinoma cell lines represent a novel target for a chimeric protein composed of IL-13 and a mutated form of Pseudomonas exotoxin. J Urol 1997;158(3 Pt 1):948-53.
32. Foord SM, Marshall FH. RAMPs: accessory proteins for seven transmembrane domain receptors. Trends Pharmacol Sci 1999;20:184-7.
33. Evans BN, Rosenblatt MI, Mnayer LO, Oliver KR, Dickerson IM. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem 2000;275:31438-43.
34. Pedeux R, Lefort K, Cuenin C, Cortes U, Kellner K, Dore JF, Nakazawa H. Specific induction of gadd45 in human melanocytes and melanoma cells after UVB irradiation. Int J Cancer 2002;98:811-6.
35. Dell'Era P, Coco L, Ronca R, Sennino B, Presta M. Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. Oncogene 2002;21:2433-40.
36. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Yamamoto H, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002;109:113-24.
37. Andreasen PA, Kjoller L, Christensen L, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 1997;72:1-22.
38. Dear AE, Medcalf RL. The urokinase-type-plasminogen-activator receptor (CD87) is a pleiotropic molecule. Eur J Biochem 1998;252:185-93.
39. Kawakami M, Kawakami K, Puri RK. Intratumor administration of interleukin 13 receptor-targeted cytotoxin induces apoptotic cell death in human malignant glioma tumor xenografts. Mol Cancer Ther 2002;1:999-1007.
40. Barth S. hIL-13-PE38QQR. NeoPharm. Curr Opin Invest Drugs 2001;2:1309-13.
41. Lee LF, Hellendall RP, Wang Y, Haskill JS, Mukaida N, Matsushima K, Ting JP. IL-8 reduced tumorigenicity of human ovarian cancer in vivo due to neutrophil infiltration. J Immunol 2000;164:2769-75.
42. Martinez A, Vos M, Guedez L, Kaur G, Chen Z, Garayoa M, Pio R, Moody T, Stetler-Stevenson WG, Kleinman HK, Cuttitta F. The effects of adrenomedullin overexpression in breast tumor cells. J Natl Cancer Inst 2002;94:1226-37.
43. Oehler MK, Hague S, Rees MC, Bicknell R. Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis. Oncogene 2002;21:2815-21.